Indeed, measurements of cancer driver pathway activation, such as Src,8 RhoA 9 and Rac,7 have recently been reported using in vivo FLIM imaging of FRET (Fluorescence Resonance Energy Transfer) biosensors, and others have shown that multi-modal CARS 2-photon imaging can be combined with FLIM.35 This evidence concerns the gene AKT1 and cancer.